The Company s scientific founder, Dr. Simon Skurkovich, was the first to propose the novel approach to the treatment of autoimmune disease, which involves the removal of certain immunomodulators called cytokines. This therapeutic strategy has now received universal validation by the biotechnology industry as evidenced by numerous publications supporting the work of Dr. Skurkovich. The Company holds a proprietary position on a number of anti-cytokine treatment paradigms and has generated preliminary clinical data in 142 patients demonstrating the potential safety and efficacy of its treatment protocols in both Multiple Sclerosis and Rheumatoid Arthritis. Advanced Biotherapy operates on the virtual company model with a small staff. This allows the Company to focus resources on projects rather than infrastructure.
Management is equity motivated and projects are outsourced using experienced industry experts.
Our internal operations staff closely manages these projects. Advanced Biotherapy Inc. All rights reserved. Terms and Conditions governing the use of this Web site.